SBI Securities’s Sonoma Pharmaceuticals SNOA Stock Holding History

SBI Securities’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$4	–	4201
2025 Q3	$4	Buy	+1	New	+$4	﹤0.01%	4122

Other funds holding SNOA

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

SBI Securities's SNOA Position: Q4 2025 in Review

SBI Securities sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2025, closing a stake of 1 share — an estimated $4 sold.

SBI Securities first reported a position in SNOA in Q3 2025 and held it in 1 quarter. The position peaked at $4 in Q3 2025. 16 funds tracked by Wall St. Rank hold SNOA as of Q4 2025.

SBI Securities reported no remaining Sonoma Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 1 Sonoma Pharmaceuticals share in Q4 2025, an estimated $4.
SBI Securities first reported a position in Sonoma Pharmaceuticals in Q3 2025 and held it in 1 quarter.
SBI Securities's Sonoma Pharmaceuticals position peaked at $4 in Q3 2025.
16 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.